Learn about PCT, PCT kinetics, managing sepsis, and antibiotic stewardship in this video library. To learn more, visit the B·R·A·H·M·S PCT Education page.

Clinical Perspectives

The role of B·R·A·H·M·S PCT: Introduction

Dr. Gluck discusses the challenges in diagnosing and treating systemic bacterial infections and the role of procalcitonin in this short video. 

PCT perspectives: For antibiotic stewardship

B·R·A·H·M·S PCT is a critical component to reduce unneeded antibiotic usage and limit antibiotic exposure in LRTI and Sepsis.

PCT perspectives: The emergency department

B·R·A·H·M·S PCT is an invaluable marker to help assess presence or absence of a bacterial infection in the Emergency Department. Clinical insight is given by Dr. Neath in this short informative video. 

PCT perspectives: The critical care perspective

Dr. Gluck highlights how B·R·A·H·M·S PCT is used to help assess presence or absence of a bacterial infection in the Intensive Care Unit.

PCT perspectives: The pharmacy

B·R·A·H·M·S PCT can be used to help customize antibiotic therapy for patients with bacterial infections. Dr. Broyles provides real-world insight and experience.

Understanding PCT kinetics

This new video explains the unique kinetics of PCT in response to inflammatory processes resulting from bacterial infection.

Scientific Presentations 

Webinar: Procalcitonin as an Aid for Risk Assessment in COIVD-19 (SARS-CoV-2) and Influenza Related Secondary Infections

PCT now also demonstrates evolving evidence as a valuable tool in current COVID-19 epidemics to aid in early identification of patients at low risk of bacterial infection on  admission as well as assist in detection of bacterial co-infection in hospitalized patients.  

Procalcitonin 2019: Potential and Pitfalls

Gregory B. Seymann MD, SFHM
Clinical Professor
Vice Chief, Academic Affairs
UCSD Hospital Medicine

Improving risk assessment for sepsis

Dr. Eric Gluck, Chicago's Swedish Convenant Hospital

Every year, severe sepsis affects more than three quarters of a million patients—and as many as 40 percent of these patients die. Dr. Gluck explains how early identification of septic patients is crucial. 

Introduction to sepsis

Stephen Barnes, BSN, RN, alumnus CCRN, clinical consultant, Thermo Fisher Scientific

Mr. Barnes provides an overview of sepsis, incidence of sepsis in the U.S., importance of early detection, treatments for sepsis, and survival rates.

Clinician and laboratory perspectives in sepsis patient management and CMS core measurements

If you missed this informative workshop at AACC 2016, here's your opportunity to learn more about strategies for managing patients with severe sepsis and septic shock.